Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225608 · ClinicalTrials.gov registry record · NA
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
A NA study of Mood and Exercise Performance, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT07225608: Completed NA study of Mood and Exercise Performance, sponsored by Applied Science & Performance Institute.
NCT07225608 is a NA study of Mood and Exercise Performance that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 27 participants, below the 3,659-participant average among 29 other Mood trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225608, a NA study of Mood and Exercise Performance, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn if a new pre-workout supplement can improve exercise performance in healthy adults. It will also look at how the supplement affects mood and energy levels. The main questions it aims to answer are: Does the pre-workout supplement improve endurance and strength during exercise? Does it reduce how hard exercise feels (perceived exertion)? How does it affect participants' mood and energy? Researchers will compare the pre-workout supplement to a placebo (a look-alike powder that contains no active ingredients) to see if it works. Participants will: Take the pre-workout supplement or a placebo before exercise in two separate sessions; Complete exercise tests after taking each one; Report how they feel during and after exercise, including mood, energy, and effort. By bridging gaps in existing research, this study aims to establish a robust scientific foundation for the application of this novel pre-workout supplement in enhancing exercise outcomes.
Primary Outcome
Participants will complete a graded cycling test on a calibrated cycle ergometer to assess aerobic performance. Maximal oxygen consumption (VO₂max) will be noted if a plateau is observed. using a metabolic cart to determine VO₂max.VO₂max represents the highest rate of oxygen consumption achieved during the test. Proper cycle ergometer setup, including seat height and handlebar position, will be standardized for all participants. Testing will be conducted by trained technicians for consistency.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Control placebo
- DIETARY_SUPPLEMENT proprietary pre-workout supplement
Study Locations (1)
Florida
- Applied Science & Performance Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-02-09 |
| Phase | NA |
What the finished NCT07225608 record still lists
NCT07225608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 3,659-participant average among 29 other Mood trials with a reported enrollment target (99% lower).
The record links to 6 conditions, with Mood appearing as the primary indexed condition, and to 2 interventions - of which Control placebo is the first listed.
NCT07225608 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07225608 about?
NCT07225608 is a clinical study titled "The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition". The goal of this study is to learn if a new pre-workout supplement can improve exercise performance in healthy adults. It will also look at how the supplement affects mood and energy levels. The main questions it aims to answer are: Does the pre-workout supplement improve endurance and strength du...
What is the current status of trial NCT07225608?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2025-12-01. Estimated completion is 2026-02-09.
What conditions does trial NCT07225608 study?
This clinical trial studies the following conditions: Mood, Exercise Performance, Energy, Physical Performance, Endurance Exercise.
What interventions are being tested in trial NCT07225608?
The interventions under investigation include: Control placebo (DIETARY_SUPPLEMENT), proprietary pre-workout supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07225608?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225608 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07225608's enrollment target sits among peer trials
27 23rd of 29 higher than 7 of 29 other Mood trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mood trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Developing Resilience and Anxiety Management Through the Arts
RECRUITING · NA
-
Impact of Bright Light Therapy on Prader-Willi Syndrome
RECRUITING · NA
-
Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
RECRUITING · NA
-
Intern Health Study 2024
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI